Do You Still Have A Reason To Buy Pliant Therapeutics Inc (NASDAQ: PLRX) After A -51.53% Drop In The Last Week?
During the last session, Pliant Therapeutics Inc (NASDAQ:PLRX)’s traded shares were 1.89 million, with the beta value of the company hitting 1.32. At the end